If you are wondering whether clinical trials might be an option for your child, you are not alone. Our patient navigators provide free, expert guidance to help families understand their options, with no obligation to enroll or move forward.

If your child was recently diagnosed with Duchenne muscular dystrophy, you are likely facing overwhelming questions. Many families feel alone in navigating what comes next.
Duchenne affects each child differently, making it hard to plan for your family's future.
Research is constantly changing, and with the different options available, it can be hard to know which path is right for you.
With so much information about trials and treatments, it can be hard to know what to trust.
You do not have to navigate this journey alone. Our patient navigators can help you explore whether clinical trials are an option.

Clinical trials are research studies that test new treatments to determine if they are safe and effective. For Duchenne, trials might explore new types of treatments or different approaches to managing symptoms and slowing progression. These treatments are investigational, which means researchers are still studying them and they are not yet approved.
Possible access to investigational treatments not yet availableÂ
Regular check-ups and care from the clinical trial team
Contributing to Duchenne research may help future generations
Important to know: Clinical trials are not right for everyone, involve risks, and do not guarantee benefit. A conversation with a patient navigator can help you understand whether exploring clinical trials make sense for your child, and what questions to ask before making any decisions.
How we help
Our patient navigators specialize in Duchenne and understand how the disease affects children differently over time. They use a continuously updated trial database to stay on top of the latest Duchenne studies and find options that may fit your child’s age, mutation, treatments, and current abilities.

Taking part in a research study can feel overwhelming. We've simplified the first steps to make it as easy as possible to learn more.
Complete a short form and immediately choose a call time that works for your family. It takes just a few minutes and is kept fully confidential.
During your free 15-30 minute call, your navigator will discuss your child's specific situation, answer your questions, and walk you through clinical trials that may be a match for you to consider.Â
If you are interested in one of your clinical trial options, your navigator can support you with next steps. You stay in control every step of the way.
Free service
Support for families at no cost
Language supportÂ
Speak with a navigator in 15+ languagesÂ
No obligationÂ
Explore options without commitment
IndependentÂ
We provide an unbiased overview of available clinical trials that may be relevant for your child
Not medical adviceÂ
Our navigators help you understand available trial options so you can make informed decisions with your care team
Since 2012, we have supported thousands of families across 135+ countries in navigating rare disease clinical trials—including hundreds of families affected by Duchenne muscular dystrophy. We are an independent service, which means our navigators provide unbiased support focused on your child’s unique situation.

6,000+Â
Duchenne families supported worldwide
Independent serviceÂ
Unbiased, patient-first support
Rare disease expertiseÂ
Access to trials across multiple countries
Supporting children and families with Duchenne is a commitment I hold close to my heart. I know how overwhelming the rapid pace of finding clinical trials can feel. As your navigator, my purpose is to bring clarity to the journey and empower families to make the choice that feels right for their child.

Theo Cantero
Patient navigator specializing in neuromuscular diseasesÂ
If your child has Duchenne, there may be clinical trial options to explore, depending on age, genetic mutation, and medical history. Duchenne clinical trials can be mutation-specific and may have requirements related to walking ability, current medications (like steroids), or heart and lung health[Lm1.1]. A short call with a navigator can help you understand which clinical trial options may be relevant for your child’s situation and what may be worth keeping an eye on as new clinical trials open.
It depends on what feels manageable for your family, such as how your child is doing today, how much time and travel you could take on, and whether you want to explore options now or simply stay informed. A navigator can help you understand what exploring clinical trial options could involve and help you prepare questions to discuss with your child’s specialist. You can explore options without committing to anything, and you decide what happens next
You’ll speak with a navigator who will ask a few questions about your child’s diagnosis and current care, so we can understand what clinical trial options might be relevant. If you have genetic results, it helps to share them—but you don’t need everything ready to start. After the call, we’ll explain what options may be a match (if any) and what next steps could look like, including what you could discuss with your child’s specialist. You choose what happens next, and we won’t contact any clinical trial team without your permission.
Booking a call is not a commitment to joining a clinical trial. Many families speak with a navigator simply to understand what clinical trial options may exist and what joining a clinical trial could involve—even if they’re not ready to take part right now. After the call, you can decide what (if anything) you want to do next, including just staying informed. If you ever choose to move forward, that would only happen after speaking with your child’s doctor and the clinical trial team at the trial site, who can give you the full details of the trial. You decide if and when you want to explore any next step.[L
That can happen and it’s common. Duchenne clinical trials may have specific requirements related to age, mutation type, walking ability, current treatments, or heart and lung health[Lm1.1]. If your child isn’t eligible right now, your navigator can explain why, help you understand what to watch for, and keep you informed as new clinical trials open [Lm2.1][Rv2.2][Lm2.3]or criteria change. You can still use the call to get clarity and plan your next steps with your child’s specialist.
Not necessarily, but genetic results are often helpful, because many Duchenne clinical trials are mutation-specific. If you already have results, you can share them during or after the call. If you don’t, your navigator can explain why mutation information matters and what to discuss with your child’s care team to get the right details. Either way, you can still speak with a navigator to understand what options may exist now and what to keep an eye on for the future. We’ll only share information with a clinical trial team if you ask us to.
Sometimes, yes. Many Duchenne clinical trials take place at specialized hospitals, and joining a trial may require in-person visits for tests and check-ups. How much travel is needed depends on the specific clinical trial—some have sites in multiple regions, while others are only available in a few locations. Your navigator can help you understand what joining a clinical trial could involve, including where sites are located and what the visit schedule may look like. If you’re interested in a specific option, the clinical trial team can confirm practical details, including any travel support.
No, there’s no cost to speak with a myTomorrows patient navigator. The call is for information and guidance, so you can understand what clinical trial options may be relevant and what next steps could look like. You can decide what (if anything) you want to do after the call. You can take the information and decide what feels right for your family.
Yes. We handle any medical information you share securely and use it only to assess whether clinical trial options may be relevant. We will not share your information with any clinical trial team or hospital without your clear permission. You can ask questions, choose what you want to share, and decide what happens next.
A clinical trial is a research study that tests a new treatment or approach to see how safe it is and how well it works to treat a medical condition. Clinical trials follow strict rules and are reviewed by independent ethics committees to help protect participants. What’s involved can vary by trial, including clinic visits, tests, and how the treatment is given. If you’re exploring options for Duchenne, a navigator can help you understand what clinical trial options may be relevant and what joining a trial could involve. Joining a clinical trial is always voluntary.
Families consider Duchenne clinical trials for different reasons. Often, they want to learn about new treatment approaches—especially if current treatment options feel limited or do not fit their child’s specific situation.[Lm1.1][Rv1.2] Other families value the regular check-ups and specialist follow-up that can come with joining a clinical trial. Some also want to support progress in Duchenne research that may help others in the future. A navigator can help you understand what clinical trial options may be relevant and what joining a trial could involve, so you can discuss options with your child’s care team.
Duchenne clinical trials follow strict safety rules, but there can still be risks and side effects. Before a child can join a trial, the clinical trial team reviews medical information to check whether the trial is appropriate. During the clinical trial, children are monitored closely through regular visits and tests. Clinical trials are also reviewed by independent ethics committees to help protect participants. If you’re exploring options, a navigator can explain what safety monitoring often looks like and what questions to ask a clinical trial team. Joining a clinical trial is always your choice, and you can stop at any time.
Show less
Show more
Complete this form to schedule your free call with a Duchenne patient navigator. You can choose your preferred time and language on the next page.
Important: If you are a caregiver, please note that the patient’s legal guardian needs to be present on the call. A legal guardian is someone who has the legal right to make decisions for the patient, such as a parent of a minor or a court-appointed representative.

Published Sept, 2024
A practical overview of Duchenne muscular dystrophy, including symptoms, how it is diagnosed, and the treatment and care options available today and in development.Â

Published Sept, 2025
A clear overview of today’s Duchenne treatment options and the progress being made through ongoing research and clinical trials.

Published Jun, 2025
A guide to the genetic causes of Duchenne, how it is inherited, and the different genetic testing options available, including testing during pregnancy.

mytomorrows.com is published by Impatients N.V., Anthony Fokkerweg 61, 1059 CP, Amsterdam, The Netherlands. VAT: NL 8516 3386 9B01, Chamber of Commerce: 55272169
© 2026 myTomorrows. All rights reserved.
Privacy statementTerms of use